We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Heska Corporation | NASDAQ:HSKA | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 119.99 | 109.74 | 130.24 | 0 | 01:00:00 |
From May 2019 to May 2024
LOVELAND, Colo., Oct. 16, 2018 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, plans to announce its third quarter 2018 financial results in a press release on Tuesday, November 6, 2018 before the market opens and to host a conference call on the results at 9 a.m. MT / 11 a.m. ET on the same day.
To access the conference call:
From within the United States, please dial 1-866-548-4713
From outside of the United States, please dial 1-323-794-2093
Reference Conference ID: 8134026
The conference call will be webcast live from the Company's website on www.heska.com.
A telephonic replay of will be available beginning at 2 p.m. ET and continue through 11:59 p.m. ET on Tuesday, November 13, 2018. The webcast will be archived on www.heska.com for 90 days.
To access the replay:
From within the United States, please dial 1-844-512-2921
From outside the United States, please dial 1-412-317-6671
Reference Replay Pin Number: 8134026
About Heska
Heska Corporation (NASDAQ: HSKA - News) manufactures, develops and sells advanced veterinary diagnostic and healthcare products. Heska's Core Companion Animal Health ("CCA") segment represents approximately 80% of revenues and Other Vaccines, Pharmaceuticals and Products ("OVP") segment represents approximately 20% of revenues. CCA segment includes, primarily for canine and feline use, Point of Care Laboratory testing instruments and consumables under a unique multi-year Reset Subscription model, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. OVP segment includes, primarily for herd animal health, private label vaccine and pharmaceutical production under third party agreements and channels. For further information on Heska and its products, visit www.heska.com.
View original content:http://www.prnewswire.com/news-releases/heska-schedules-third-quarter-2018-financial-results-conference-call-for-november-6-2018-300731275.html
SOURCE Heska Corporation
Copyright 2018 PR Newswire
1 Year Heska Chart |
1 Month Heska Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
